(Press-News.org) A team led by University of Pittsburgh’s Graham Hatfull has developed a method to construct bacteriophages with entirely synthetic genetic material, allowing researchers to add and subtract genes at will. The findings open the field to new pathways for understanding how these bacteria-killing viruses work, and for potential therapy of bacterial infections.
As phages’ secrets are revealed, researchers will be able to engineer them with genomes tailor-made to attack specific bacteria, leading to new ways to combat the worsening problem of antibacterial resistance.
Contact Professor Graham Hatfull: gfh@pitt.edu
“This will speed up discovery,” Hatfull said. There is massive variation among phages, but researchers don’t know the roles played by many individual genes. “How are the genes regulated? If a phage has 100 genes, does it need all 10? What happens if we remove this one or that one? We don’t have the answers to those questions,” he said, “but now we can ask–and answer–almost any question we have about phages.”
For this research, the team reconstructed two naturally occurring phages that attack mycobacterium (which include the pathogens responsible for tuberculosis and leprosy, among others) using synthetic material. They then added and removed genes, successfully editing the synthetic genomes of both.
“And now, the sky's the limit,” Hatfull said. “You can make any genome you want. You're only limited by what you can imagine would be useful and interesting to make.”
Graham collaborated with Ansa Biotech and New England Biolabs, combining their unique techniques for synthesizing and assembling DNA with his expertise in phages and mycobacterium. The results of their work will be published in Proceedings of the National Academy of Sciences (PNAS).
END
Phages with fully-synthetic DNA can be edited gene by gene
2025-11-10
ELSE PRESS RELEASES FROM THIS DATE:
Investigational daily pill lowered bad cholesterol as much as injectables
2025-11-10
Research Highlights:
For people who have experienced a heart attack or stroke, or who are at high risk of one and need further cholesterol lowering, a new daily pill may be a more convenient yet similarly effective option to injectable therapies.
The oral medication, enlicitide, lowered LDL cholesterol by up to 60% and could eventually offer an option for people whose LDL levels remain above goal despite lifestyle changes and standard cholesterol medications like statins.
A longer, ongoing cardiovascular outcomes study will examine whether enlicitide can reduce the risk of heart attack or stroke.
Note: The study featured ...
Researcher seeks to understand delays in language development
2025-11-10
Nancy Brady has been gratified to see the tool she and colleagues pioneered over a decade ago to measure the growth of infants’ pre-speech communication skills translated into several languages and referenced in more than 100 research papers, including a åçnew one published in the Journal of Speech, Language and Hearing Research.
Brady, a professor in the University of Kansas Department of Speech-Lanuage-Hearing: Sciences & Disorders, and her now-former graduate student Olivia Boorom were among the co-authors of a new paper ...
Medication still better than procedure for some irregular heartbeat conditions
2025-11-10
Research Highlights:
Standard care, which included medication for those eligible, was better than a promising minimally invasive procedure for people with irregular heart rhythms who had high stroke and bleeding risk.
The procedure seals off a small pouch of heart tissue, where most blood clots form in people with irregular heartbeat. However, in older people, standard care, including the use of blood thinners when indicated, did a better job at prevention of stroke, blood clots, cardiovascular or unexplained death ...
Understanding how bacteria use “sunscreen” to adapt to climate
2025-11-10
Cyanobacteria, commonly known as blue-green algae, are found almost everywhere in the world—from hot springs to arctic ice to antioxidant smoothies.
Part of their extreme adaptability lies within a unique light-harvesting structure called the phycobilisome. These modular antennae both collect energy from sunlight, and adapt to changing light levels in order to provide a sort of sunscreen for the bacteria.
One important way that phycobilisomes adapt involves an accessory protein to both sense and protect against too much light. ...
Inaugural Margot and Tom Pritzker Prize for AI in Science Research Excellence announces winners at conference
2025-11-10
The University of Chicago and Caltech announce the recipients of the inaugural Margot and Tom Pritzker Prize for AI in Science Research Excellence, presented during the AI+Science Conference hosted at Caltech on November 10 and 11. This new award recognizes outstanding contributions that jointly advance artificial intelligence and the natural sciences or engineering.
“We see AI as a catalyst for human ingenuity—accelerating the scale and pace of discovery in ways that can meaningfully benefit humanity. We hope that this initiative will help scientists to reach farther to explore frontiers once thought unreachable,” said Margot Pritzker and Tom ...
COP webpages emit seven times more carbon than average sites
2025-11-10
Websites produced for COP conferences emit up to seven times more carbon than average internet pages, new research suggests.
Ahead of this year’s United Nations climate summit, COP30, researchers have revealed a sharp increase in the carbon emissions generated by the conference’s websites over time.
Analysis indicates that between 1995 – when the first Conference of the Parties (COP) was held – and 2024, average emissions from COP conference websites have risen by more than 13,000%.
While ...
Successful visualization of the odor discrimination process in an AI-assisted olfactory sensor
2025-11-10
NIMS has been developing chemical sensors as a key component of the artificial olfaction technology (olfactory sensors), with the aim of putting this technology into practical use. In this study, explainable AI (XAI) was used to reveal how chemical sensors discriminate among various odorant molecules. The findings may help guide the selection of receptor materials for developing high-performance chemical sensors capable of detecting odorant molecules. The achievement is expected not only to improve the performance of artificial olfaction but also to advance understanding of human olfactory mechanisms. This ...
Patients with peripheral arterial disease who also have atrial fibrillation face significantly higher risk for cardiac events including death
2025-11-10
New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) who also have atrial fibrillation (AFib) face a significantly higher risk of major adverse cardiovascular events (MACE).
The Intermountain study analyzed long-term data of Intermountain Health patients with PAD and found that AFib was present in approximately one in four PAD patients, making this combination far more common than previously recognized.
More importantly, Intermountain researchers found the presence of AFib nearly doubles the risk of major adverse cardiovascular events in patients compared to PAD alone.
Irregular heart rhythms are called arrhythmias. ...
Factoring in frailty and age to improve pancreatic cancer treatment
2025-11-10
While some risk factors for cancer can be mitigated through lifestyle choices such as diet or exercise, aging is not one of them. In the case of pancreatic cancer, it also can limit treatment options if a patient is too frail to be safely treated with surgery or other alternatives.
Scientists at the NCI-Designated Cancer Center at Sanford Burnham Prebys Medical Discovery Institute would like to expand options for these patients with personalized treatments. Many stand to benefit from a therapeutic strategy that factors in age. The average age of a patient diagnosed with pancreatic cancer is 70, and nearly two-thirds of cases are in people over the age of ...
Preclinical support for using psychedelics to treat alcohol use disorders
2025-11-10
A psychedelic found in mushrooms is emerging as a potential treatment for alcohol use disorders. This possibility is due to a compound the body converts the psychedelic into called psilocin, but psilocin’s mechanisms remain unclear. Researchers, led by Sarah Magee and Melissa Herman at University of North Carolina at Chapel Hill, explored whether psilocin targets neurons in the central amygdala involved in emotional processing and stress to alter alcohol use in their JNeurosci paper. Herman emphasizes that ...